Valuation : Pathkey.AI Ltd

Market Cap 47.26M 34.04M 29.31M 27.56M 25.15M 47.07M 3.22B 326M 126M 1.65B 128M 125M 5.32B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 43.85M 31.58M 27.19M 25.57M 23.34M 43.67M 2.98B 302M 117M 1.53B 119M 116M 4.94B EV / Sales 2025
21.1x
EV / Sales 2026 292x
Free-Float
59.45%
Yield 2025 *
-
Yield 2026 -
1 day-5.41%
1 week-14.63%
Current month-14.63%
1 month+20.69%
3 months-12.50%
6 months+40.00%
Current year+118.75%
1 week 0.04
Extreme 0.035
0.04
1 month 0.03
Extreme 0.03
0.05
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 16/01/1994
Chief Executive Officer - 10/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 20/10/2025
Director/Board Member - 20/10/2025
Chairman - 25/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-5.41%-14.63%+16.67%-30.00% 35.95M
-3.27%-2.50%+1.53%+27.02% 46.04B
+0.72%-2.95%-40.18%+138.42% 12.98B
-0.14%+2.54%-12.05%+71.43% 5.87B
-1.61%+1.68%+56.36% - 4.32B
+0.31%+3.93% - - 2.1B
-1.29%+2.87%+4.72%-39.74% 1.59B
+1.43%+1.86%-33.43% - 1.08B
+0.59%-0.39%+31.04%+151.22% 1.01B
-5.69%-8.96%+44.46%+50.76% 987M
Average -1.44%-0.59%+7.68%+52.73% 7.6B
Weighted average by Cap. -2.03%+0.35%-3.13%+52.53%

Financials

2025 2026
Net sales 322K 232K 200K 188K 171K 321K 21.91M 2.22M 862K 11.23M 871K 852K 36.24M 269K 193K 167K 157K 143K 267K 18.27M 1.85M 719K 9.37M 726K 710K 30.22M
Net income -1.45M -1.04M -898K -844K -770K -1.44M -98.51M -9.97M -3.87M -50.51M -3.91M -3.83M -163M -3.65M -2.63M -2.27M -2.13M -1.94M -3.64M -249M -25.16M -9.77M -127M -9.88M -9.66M -411M
Net Debt -25.17K -18.12K -15.61K -14.67K -13.39K -25.06K -1.71M -173K -67.34K -878K -68.05K -66.57K -2.83M -3.41M -2.46M -2.11M -1.99M -1.81M -3.4M -232M -23.49M -9.12M -119M -9.22M -9.02M -384M
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
04/09/26 A$0.0350 -5.41% 4,090,557
03/09/26 A$0.0370 -9.76% 1,798,148
02/09/26 A$0.0410 +5.13% 1,016,932
01/09/26 A$0.0390 -4.88% 2,397,954
31/08/26 A$0.0410 -8.89% 3,872,218